What is the recommended screening protocol for Retinopathy of Prematurity (ROP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ROP Screening Protocol

All infants born at less than 32 weeks gestational age or with birth weight less than 1500g should undergo their first retinopathy of prematurity (ROP) screening examination at 31 weeks postmenstrual age (or 4 weeks chronological age, whichever is later), performed by an ophthalmologist experienced in ROP evaluation. 1

Initial Screening Criteria

Who Needs Screening

  • Mandatory screening: All infants <32 weeks gestational age at birth, regardless of clinical course 1
  • Selective screening: Infants 29-37 weeks gestation who had an unstable medical course (supplemental oxygen requirement) or chronic lung disease of infancy (CLDI) 1
  • No screening needed: Infants >37 weeks gestational age 1

The conservative approach of screening all infants <32 weeks is preferred over relying on "medically stable" criteria, as this reduces the risk of missing cases 1.

Timing of First Examination

  • Standard timing: 31-33 weeks postmenstrual age OR 4 weeks chronological age, whichever comes later 1
  • The examination must be conducted by an ophthalmologist skilled in evaluating the premature infant retina 2, 1

Examination Technique

Preferred Method

  • Binocular indirect ophthalmoscopy remains the reference standard for ROP diagnosis 3
  • Use +20 or +28 diopter lens with indirect ophthalmoscope 4
  • Mydriasis achieved with tropicamide 1% and phenylephrine 2.5% 4

Alternative Screening Modalities

  • Retinal photography (RetCam) can be used as an adjunct but should not replace indirect ophthalmoscopy due to insufficient sensitivity (68%) for detecting peripheral disease 5, 3
  • Digital imaging has excellent specificity (99%) but misses mild peripheral ROP in zone III 3
  • Telemedicine approaches are acceptable when coupled with timely referral pathways for abnormal findings 2

Follow-Up Examination Schedule

Based on Initial Findings

If no ROP detected and incomplete vascularization:

  • Repeat examination every 2 weeks until vessels reach ora serrata 4
  • Then extend to every 3-4 weeks until complete vascularization 4

If any stage of ROP present:

  • Zone I or Zone II disease: Weekly or every 1-2 weeks depending on severity 1, 6
  • Zone III with regression: Every 2 weeks until vessels pass into Zone III on two sequential exams 1, 7

If prethreshold or threshold disease:

  • Weekly examinations until treatment or regression 6

Discontinuation Criteria

Screening can be safely discontinued when:

  • Complete retinal vascularization documented 1, 6
  • ROP regressing with vessels passed into Zone III on at least two sequential examinations 1, 7

Continue screening if:

  • Vessels or ROP remain in Zone I or Zone II (highest risk for progression) 1, 6
  • History of CLDI even with Zone III disease 1

Critical Pitfalls to Avoid

Missed Follow-Up Appointments

  • Greatest risk: Infants with unresolved ROP in Zone I or II discharged home who miss appointments 1, 6
  • This represents the most common cause of preventable vision loss from ROP 1
  • Careful coordination of outpatient ophthalmology appointments is essential before discharge 1

Premature Discontinuation

  • Do not stop screening based solely on postmenstrual age 1
  • Incomplete vascularization at 32 weeks leaves retina vulnerable to injury 1
  • Continue until anatomic criteria for discontinuation are met 1, 7

Special Population Considerations

Infants with CLDI:

  • Require screening even if 29-37 weeks gestation 1
  • Need more frequent follow-up due to higher risk 1, 6
  • Oxygen management becomes critical—target saturation ≥95% once past acute ROP risk period 6

Treatment Threshold

  • Peripheral ablation (laser or cryotherapy) proven effective for threshold ROP 6
  • Treatment decisions based on Early Treatment for ROP (ETROP) criteria 5
  • Timely treatment within appropriate window prevents blindness 6

References

Guideline

Timing of First ROP Screening Examination in Newborns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Retinopathy of prematurity (ROP): optimal timing of clinical evaluation and standard procedures.

Documenta ophthalmologica. Advances in ophthalmology, 1990

Guideline

Treatment and Management of Retinopathy of Prematurity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Long-term Follow-up for ROP Stage Zero Zone 3

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.